申请人:YALE UNIVERSITY
公开号:US10278989B2
公开(公告)日:2019-05-07
The present invention relates to the use of pharmaceutically acceptable zinc salts, in particular, zinc chloride and zinc acetate, alone or optionally, in combinations with one or more of a protein pump inhibitor (PPI), H2 blocker, anti-H. pylori antibiotic/antimicrobial, cytoprotective agent or a combination agent as otherwise described herein for providing fast action with optional long duration effect in reducing gastric acid secretion, including acid secretion in the fundus (by inhibiting vacuolar H+-ATPase or H+/K+-ATPase) and upper body region of the stomach (by inhibiting H+/K+-ATPase), thus raising the pH of gastric juices in rapid fashion and decreasing the duration of stomach acid release during a secretagogue phase. This method is also directed to treating conditions including gastroesophageal reflux disease (GERD), non-erosive reflux disease (NERD), Zollinger-Ellison syndrome (ZE disease), ulcer disease, and gastric cancer, as well as preventing or reducing the likelihood of ulcer disease. In addition, the present methods are useful for treating patients who are non-responsive to proton pump inhibitors (PPI) and as an alternative to traditional therapies or conditions which are caused by rapid and complete inhibition of secretagogue induced acid secretion.
本发明涉及药学上可接受的锌盐,特别是氯化锌和醋酸锌,单独或与一种或多种蛋白泵抑制剂(PPI)、H2 受体阻滞剂、抗幽门螺杆菌抗生素/抗菌剂、细胞保护剂或本文所述的复方制剂组合使用,以提供快速作用和可选的长效作用,减少胃酸分泌,包括胃酸在胃中的分泌。特别是氯化锌和醋酸锌,单独使用或与一种或多种蛋白泵抑制剂(PPI)、H2 受体阻滞剂、抗幽门螺杆菌抗生素/抗菌剂、细胞保护剂或本文另外描述的复方制剂联合使用,可在减少胃酸分泌,包括胃底(通过抑制空泡 H+-ATP 酶或 H+/K+-ATP 酶)和胃上部(通过抑制 H+/K+-ATP 酶)的胃酸分泌方面提供快速作用和可选的长效作用,从而快速提高胃液的 pH 值,减少分泌期胃酸释放的持续时间。本方法还可用于治疗胃食管反流病(GERD)、非胃食管反流病(NERD)、卓-艾综合征(ZE 病)、溃疡病和胃癌等疾病,以及预防或降低溃疡病的可能性。此外,本方法还可用于治疗对质子泵抑制剂(PPI)无反应的患者,并可替代传统疗法或因快速、完全抑制分泌物诱导的酸分泌而导致的病症。